J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
|
IN |
|
B
|
Bright Outdoor Media Ltd
BSE:543831
|
IN |
|
C
|
Clovis Oncology Inc
XETRA:C6O
|
US |
|
O
|
One to One Contacts PCL
SET:OTO
|
TH |
|
Mitchell Services Ltd
ASX:MSV
|
AU |
|
Shenzhen United Winners Laser Co Ltd
SSE:688518
|
CN |
|
T
|
Turker Proje Gayrimenkul Ve Yatirim Gelistirme AS
IST:TURGG.E
|
TR |
|
A
|
Ashok Alco-Chem Ltd
BSE:524594
|
IN |
|
Samkrg Pistons and Rings Ltd
BSE:520075
|
IN |
|
Oil Country Tubular Ltd
NSE:OILCOUNTUB
|
IN |
|
B
|
Beijing ZEHO Waterfront Ecological Environment Treatment Co Ltd
SSE:605069
|
CN |
|
S
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SSE:605033
|
CN |
|
Sonim Technologies Inc
NASDAQ:SONM
|
US |
|
T
|
Thirumalai Chemicals Ltd
NSE:TIRUMALCHM
|
IN |
|
G R Infraprojects Ltd
NSE:GRINFRA
|
IN |
|
Tecan Group AG
SIX:TECN
|
CH |
|
Zoetis Inc
NYSE:ZTS
|
US |
|
C
|
COFCO Sugar Holding Co Ltd
SSE:600737
|
CN |
|
S
|
Shanghai Material Trading Co Ltd
SSE:600822
|
CN |
|
Shenzhen Guangju Energy Co Ltd
SZSE:000096
|
CN |
|
Auto Italia Holdings Ltd
HKEX:720
|
HK |
|
B
|
Beijing Jetsen Technology Co Ltd
SZSE:300182
|
CN |
|
B
|
Botnia Exploration Holding AB (publ)
STO:BOTX
|
SE |
|
Z
|
Zhejiang Shengda Bio-Pharm Co Ltd
SSE:603079
|
CN |
Discount Rate
JBCHEPHARM Cost of Equity
Discount Rate
JBCHEPHARM's Cost of Equity, calculated using the formula
Risk-Free Rate + Beta x ERP,
stands at 10.74%.
The Beta, indicating the stock's volatility relative to the market, is 0.97, while the current Risk-Free Rate, based on government bond yields, is 6.69%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
JBCHEPHARM WACC
Discount Rate
JBCHEPHARM's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax.
The WACC stands at 10.76%. This includes the cost of equity at 10.74%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 40%, reflecting the interest rate on
JBCHEPHARM's debt adjusted for tax benefits. The weight of debt in the capital structure is 0.07%.
What is JBCHEPHARM's discount rate?
JBCHEPHARM
's current Cost of Equity is 10.74%, while its WACC stands at 10.76%.
The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."
How is Cost of Equity for JBCHEPHARM calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
JBCHEPHARM
How is WACC for JBCHEPHARM calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
JBCHEPHARM
